Company Filing History:
1 out of 46 
1 out of 2 Years Active: 2021-2025
Title: Tinghua Cao: Innovator in Regulatory T Cell Expansion
Introduction
Tinghua Cao is a notable inventor based in Malvern, PA (US), recognized for his contributions to the field of immunology. He holds 2 patents that focus on methods for the ex-vivo expansion of regulatory T cells, which have significant implications for treating immune-mediated diseases.
Latest Patents
Cao's latest patents include a method for ex-vivo expansion of regulatory T cells with enhanced suppressive function for clinical application in immune-mediated diseases. This invention provides methods for the ex-vivo expansion of CD4+CD25+ Tregs. The method aims to produce ex vivo expanded Tregs that can inhibit unwanted human immune responses against self-antigens or allergens. Additionally, these ex vivo expanded Tregs may offer treatment options for inflammatory and autoimmune diseases.
Career Highlights
Throughout his career, Tinghua Cao has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Mallinckrodt Pharmaceuticals and Therakos Development Limited. His work in these organizations has contributed to advancements in therapeutic strategies for immune-related conditions.
Collaborations
Cao has collaborated with various professionals in his field, including his coworker Li Li. Their joint efforts have furthered research and development in immunological therapies.
Conclusion
Tinghua Cao's innovative work in the expansion of regulatory T cells positions him as a key figure in the advancement of treatments for immune-mediated diseases. His patents reflect a commitment to improving clinical outcomes for patients suffering from these conditions.